Xylem (XYL) Tops Q1 EPS by 10c; raises Guidance

Xylem (NYSE: XYL) reported Q1 EPS of $0.72, $0.10 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.35 billion.

GUIDANCE:

Xylem sees FY2023 EPS of $3.15-$3.35, versus the consensus of $3.22.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Micron Technology (MU) PT Raised to $1,550 at Needham
• Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules